ATRIA Bleeding Risk Score

ورودی‌های بالینی بیمار

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
atria bleeding score
—points
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • Low0–3
  • Intermediate4–4
  • High5–10
Direct Clinical Answer

The ATRIA Bleeding Risk Score calculates stratifying cardiovascular risk, predicting thromboembolic events, or guiding therapeutic interventions. Key inputs include anemia. Scores guide initiating guideline-directed medical therapy, antithrombotic or anticoagulant regimens, or urgent coronary angiography. This standardized assessment improves clinical decision safety and bedside patient management.

Clinical Guidelines & Evidence

Determines bleeding risk for patients on warfarin therapy for atrial fibrillation. The score was developed and validated in the ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) cohort and helps stratify patients into low, intermediate, and high risk categories for major hemorrhage.

Clinical Indication

The ATRIA Bleeding Risk Score is indicated for bedside clinical practice to support Determines bleeding risk for patients on warfarin therapy for atrial fibrillation. The score was developed and validated in the ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) cohort and helps stratify patients into low, intermediate, and high risk categories for major hemorrhage.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Adult patients presenting with suspected or established coronary artery disease, cardiac arrhythmias, congestive heart failure, or valvular heart defects. Clinical application is indicated across Emergency department, cardiac care unit (CCU), cardiac catheterization laboratory, and outpatient cardiology clinics.

Limitations & Contraindications

In hemodynamically unstable cardiogenic shock, cardiac arrest, or refractory acute coronary syndromes, immediate resuscitation and coronary angiography supersede scoring. Clinical exclusion: Patients with a history of intracranial hemorrhage were likely excluded from the development cohort..

Clinical Pearls & Action Plan

Continuous 12-lead ECG monitoring, serial cardiac troponin measurements, and echocardiographic evaluation align with ESC/ACC/AHA clinical practice guidelines.

Formula & Variables:

ATRIA Score = Anemia (3 points) + Severe Renal Disease (3 points) + Age ≥75 (2 points) + Prior Hemorrhage (1 point) + Hypertension (1 point)

Input Parameters

NameTypeRequiredDescription
anemiastringYesPresence of anemia (Hemoglobin <13 g/dL in males or <12 g/dL in females)
severe_renal_diseasestringYesSevere renal disease (GFR <30 mL/min or dialysis-dependent)
age_75_or_overstringYesAge ≥75 years
prior_hemorrhagestringYesAny prior hemorrhage diagnosis (e.g., GI bleed, intracranial hemorrhage)
hypertensionstringYesHistory of hypertension

Score Interpretation & Guidance

RangeStageDescription
0–3LowLow bleeding risk
4–4IntermediateIntermediate bleeding risk
5–10HighHigh bleeding risk

Evidence-Based References (EBM)

  • Fang MC, Go AS, Chang Y, Borowsky LH, Pomernacki NK, Udaltsova N, et al. A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study. J Am Coll Cardiol. 2011 Jul 19;58(4):395-401. doi: 10.1016/j.jacc.2011.03.031.DOI: 10.1016/j.jacc.2011.03.031
  • Roldán V, Marín F, Fernández H, Manzano-Fernández S, Gallego P, Valdés M, et al. Predictive value of the HAS-BLED and ATRIA bleeding scores for the risk of serious bleeding in a "real-world" population with atrial fibrillation receiving anticoagulant therapy. Chest. 2013 Jan;143(1):179-184. doi: 10.1378/chest.12-0608.DOI: 10.1378/chest.12-0608
  • Senoo K, Proietti M, Lane DA, Lip GY. Evaluation of the HAS-BLED, ATRIA, and ORBIT Bleeding Risk Scores in Patients with Atrial Fibrillation Taking Warfarin. Am J Med. 2016 Jun;129(6):600-7. doi: 10.1016/j.amjmed.2015.10.001.DOI: 10.1016/j.amjmed.2015.10.001

Related calculators